IVERIC bio (ISEE) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Iveric Bio Reports Third Quarter 2022 Operational Highlights and Financial Results
November 3, 2022 6:30 AM EDT- Reported Positive GATHER2 Results for Avacincaptad Pegol in Geographic Atrophy -
- Planned NDA Submission Moved Up to End of This Year -
- Received Favorable Feedback from FDA on Intermediate AMD Development Plan -
- Conference Call and Webcast Today, November 3, 2022, at 8:00 a.m. ET -
PARSIPPANY, N.J.--(BUSINESS... More
